Aspirin for Primary Prevention of Cardiovascular Events in the Elderly Current Status and Future Directions

The role of aspirin in the secondary prevention of occlusive cardiovascular events has now been well established. Given this, aspirin in primary prevention has been the focus of several large trials and subsequent meta-analyses over the past 3 decades, and yet the issue remains controversial. Recent...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs & aging Jg. 29; H. 4; S. 251 - 258
Hauptverfasser:	Ward, Stephanie A., Demos, Lisa, Workman, Barbara, McNeil, John J.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Cham Springer International Publishing 01.04.2012 Adis International
Schlagworte:	Aged Aspirin - pharmacology Biological and medical sciences Cardiovascular Diseases - prevention & control Current Opinion Geriatrics/Gerontology Humans Internal Medicine Medical sciences Medicine Medicine & Public Health Pharmacology. Drug treatments Pharmacology/Toxicology Pharmacotherapy Practice Guidelines as Topic Randomized Controlled Trials as Topic Prasugrel Aspirin Primary Prevention Ischaemic Stroke Ticagrelor Human Prostaglandin-endoperoxide synthase Enzyme Enzyme inhibitor Cardiovascular disease Acetylsalicylic acid Review Antiplatelet agent Non steroidal antiinflammatory agent Prevention Analgesic Primary Antipyretic Oxidoreductases Salicylates Elderly
ISSN:	1170-229X, 1179-1969, 1179-1969
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!